Peking and Rotterdam on Mission to Reduce Coronary Artery Disease
Status:
Unknown status
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to explore the effect of 20mg high loading dose of rosuvastatin
on recurrent events in patients with established DM who is admitted for an ACS.